All Posts By

Smartkarma Daily Briefs

Daily Brief TMT/Internet: Tencent, Xiaomi, TSMC (Taiwan Semiconductor Manufacturing) – ADR, Meitu Inc, Contemporary Amperex Technology (CATL), Technology One and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • HK Connect SOUTHBOUND Flows (Wk To 21 Nov 2025) – BIG Net Buy on Lower Gross Flows. BABA Bought
  • Xiaomi (1810 HK): Top Trades Bet on a Bullish Trend Reversal
  • TSMC (2330.TT; TSM.US): Retired Sr. VP Joins Intel; U.S. Fab Impact; Arizona Earnings Decline.
  • Primer: Meitu Inc (1357 HK) – Nov 2025
  • Tencent (700 HK): Top Option Trades Reveal a Split in Market Sentiment
  • ECM Weekly (24 November 2025) – CATL, Hengrui, Hongqiao, WT Micro, SBI Shinsei, NS Group, Ultragreen
  • Technology One Ltd – Outlook Intact Post Tech1’s FY25 Punishment


HK Connect SOUTHBOUND Flows (Wk To 21 Nov 2025) – BIG Net Buy on Lower Gross Flows. BABA Bought

By Travis Lundy

  • HK$100bn a day of gross SOUTHBOUND activity with US$600mm+ of net buying on average. Net flows continue to be impressive. SOEs/Energy/Financials dominate.
  • Watch for news on the Dual Counter (RMB) Trading eligibility for SOUTHBOUND near-term. That could up the pace of things.
  • The data tables below update on a daily basis in the Tools section of Smartkarma. The Southbound Flow Monitor and AH Pairs Monitor are both there – free – for all SK readers.

Xiaomi (1810 HK): Top Trades Bet on a Bullish Trend Reversal

By Gaudenz Schneider

  • Context: Over the past five trading days, Xiaomi (1810 HK) multi-leg option strategies showcased a variety of approaches. Strategy highlights are provided.
  • Highlights: 55% of strategies exhibit a bullish bias, with diagonal spreads accounting for 25% of all trades.
  • Why read: This breakdown of complex option strategies sheds light on market sentiment and positioning. Detailed examples provide actionable insights that could inspire similar strategies,

TSMC (2330.TT; TSM.US): Retired Sr. VP Joins Intel; U.S. Fab Impact; Arizona Earnings Decline.

By Patrick Liao

  • TSMC (Taiwan Semiconductor Manufacturing) – ADR (TSM US)’s retired Senior Vice President Dr. Wei-Jen Lo has taken a position at Intel.
  • Trump has been in power for less than a year, and the U.S.’s measures have fully revealed its purpose of confrontation between China and the United States. 
  • TSMC’s Arizona fab profit dropped from NT$4.32 billion in 2Q25 to NT$410 million in 3Q25.

Primer: Meitu Inc (1357 HK) – Nov 2025

By αSK

  • Transition to AI-Driven Subscriptions Fueling Growth: Meitu is successfully transitioning its business model from advertising to a high-margin, AI-driven subscription service for its photo, video, and design products. This strategic shift is the primary driver behind significant revenue and profit growth, with paying subscribers reaching 15.4 million.
  • Strategic Divestment from Cryptocurrency: The company has fully divested its cryptocurrency holdings, realizing a substantial net gain of nearly US$80 million. This move de-risks the balance sheet from the volatility of digital assets and allows management to refocus capital and attention on its core AI imaging business.
  • Expanding Global Footprint and Enterprise Solutions: Meitu is aggressively expanding its international user base, which now accounts for 35% of total Monthly Active Users (MAUs). Concurrently, it is leveraging its core AI technology to launch productivity-focused tools for e-commerce and advertising, opening new avenues for enterprise revenue.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Tencent (700 HK): Top Option Trades Reveal a Split in Market Sentiment

By Gaudenz Schneider

  • Context: Over the past five trading days, Tencent (700 HK) multi-leg option strategies showcased a variety of approaches. Strategy highlights are provided.
  • Highlights: Market sentiment is evenly balanced between bullish and bearish strategies, with diagonal spreads accounting for 25% of all trades.
  • Why read: This breakdown of complex option strategies sheds light on market sentiment and positioning. Detailed examples provide actionable insights that could inspire similar strategies,

ECM Weekly (24 November 2025) – CATL, Hengrui, Hongqiao, WT Micro, SBI Shinsei, NS Group, Ultragreen

By Sumeet Singh

  • Aequitas Research’s weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
  • On the IPO front, most of the listings over the past week ended up doing well, irrespective of overall demand.
  • On the placements front, there was a lockup release for Contemporary Amperex Technology (CATL) (3750 HK), along with a number of other placements.

Technology One Ltd – Outlook Intact Post Tech1’s FY25 Punishment

By FNArena

  • Shares in TechnologyOne reacted negatively on the release of a record FY25 performance, as not all metrics met elevated expectations as as the global technology sector is de-rated.
  • -TechnologyOne delivers record FY25 metrics -Profit exceeds guidance, strong UK growth -Market concerns on softer than expected ARR and NRR -Global de-rating for the sector equally impacts on updated valuations/price targets

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: Zhejiang Leapmotor Technologie, CRH , Yum China Holdings , SK Square , Innovent Biologics Inc, Qube Holdings, InterGlobe Aviation Ltd, Monash IVF, Geekplus Technology, SBI Shinsei Bank and more

By | Daily Briefs, Most Read

In today’s briefing:

  • HSTECH Index Rebalance: Leapmotor (9863 HK) To Replace ASMPT (522 HK) As Trade Hits US$3.5bn
  • [Quiddity Index] SP500/600 Dec25 Rebal: Two ADDs Two DELs and 3 Intra-Review Changes Likely Soon
  • HSCEI Index Rebalance: 3 Changes; Yum China In; Double Add for Innovent Bio
  • Unexpected ETF-Driven Flow Event Lights up the KOSPI 200 IT Sleeve
  • Hang Seng Index (HSI) Rebalance: Innovent Biologics Turns a Profit, Gets Added
  • Qube (QUB AU): Macquarie’s Lobs NBIO
  • SENSEX Index Rebalance: InterGlobe Aviation to Replace Tata Motors PV
  • Monash IVF (MVF AU): Genesis Capital to Launch a Takeover Proposal?
  • [Quiddity Index] Dec25 Hang Seng Index Family Review; Flows for December 5 Rebal
  • Weekly Deals Digest (23 Nov) – SBI Shinsei, Toyoda Gosei, Jinke, Digital Hldgs, Webjet, RPM


HSTECH Index Rebalance: Leapmotor (9863 HK) To Replace ASMPT (522 HK) As Trade Hits US$3.5bn

By Brian Freitas


[Quiddity Index] SP500/600 Dec25 Rebal: Two ADDs Two DELs and 3 Intra-Review Changes Likely Soon

By Travis Lundy

  • The SP 500 index tracks the 500 largest names listed in the US and it is one of the most highly-tracked indices in the world.
  • In this insight, we take a look at the upcoming constituent changes in the run up to the December 2025 index rebal event.
  • We expect two regular changes in December 2025. There are also multiple live M&A events which are likely to trigger intra-review index changes.

HSCEI Index Rebalance: 3 Changes; Yum China In; Double Add for Innovent Bio

By Brian Freitas


Unexpected ETF-Driven Flow Event Lights up the KOSPI 200 IT Sleeve

By Sanghyun Park

  • If the three non-IT names exit IT, passive flows hit hard: SK Square/LG Electronics ~0.4× DTV out, LG Corp ~0.8× DTV out, new IT entrants ~0.2–0.25× DTV in.
  • If KRX surprises next Tuesday, kicking three names from IT, expect immediate tape reaction—market memory exists, but the scenario isn’t priced, unlike 2023 Kakaopay, so instant price impact is likely.
  • If this happens, June 11 turns into a chunky basket-flow day: SK Square (~15% weight) out, next-tier caps see ~0.15–0.2× DTV inflow, except ultra-liquid names like Hanmi Semi.

Hang Seng Index (HSI) Rebalance: Innovent Biologics Turns a Profit, Gets Added

By Brian Freitas


Qube (QUB AU): Macquarie’s Lobs NBIO

By David Blennerhassett

  • Qube Holdings (QUB AU), a logistics and infrastructure play, has announced a A$5.20/share non-binding indicative Offer from Macquarie Asset Management, a unit of Macquarie Group (MQG AU).
  • That is a 27.8% premium to last close. And ~14.4x FY25 EV/EBITDA. The proposal “follows an earlier unsolicited, non-=binding and indicative offer at lower value.” Dividends paid will be netted.
  • Qube directors are supportive. The proposal is conditional on due diligence, board approvals, no MACs at Qube, plus regulatory clearance, including FIRB and ACCC signing off.

SENSEX Index Rebalance: InterGlobe Aviation to Replace Tata Motors PV

By Brian Freitas

  • As forecast, InterGlobe Aviation Ltd (INDIGO IN) will replace Tata Motors (TTMT IN) in the S&P BSE SENSEX Index (SENSEX INDEX) after the close on 19 December.
  • Passive trackers will need to trade between 3.6-7.7x ADV in the stocks and that increases significantly to 7.1-12x delivery volume.
  • There are indications that positioning has built up in both stocks over the last few weeks. However, in both cases, positioning is expected to be smaller than the passive selling.

Monash IVF (MVF AU): Genesis Capital to Launch a Takeover Proposal?

By Arun George

  • The AFR reports that a mystery buyer, believed to be Genesis Capital, will launch a takeover proposal for Monash IVF (MVF AU) at A$0.80, a 31.1% premium to the last close.
  • On Friday, the mystery buyer acquired a pre-bid stake of 6.01% of outstanding shares at A$0.80. The timing is opportunistic as the shares are down 51% YTD.
  • It is unclear whether Genesis is aiming to launch a scheme or an off-market takeover offer. Nevertheless, the rumoured offer is light. 

[Quiddity Index] Dec25 Hang Seng Index Family Review; Flows for December 5 Rebal

By Travis Lundy

  • In this insight, we present the flows to buy and sell for each of the top 6 Hang Seng Index Family indices based on estimated tracking AUM.
  • The indices: Hang Seng Index (HSI), HS Tech Index (HSTECH), HS China Enterprise Index (HSCEI), HS HK Biotech (HSHKBIO), HS Internet & Infotech (HSIII), and HS Healthcare Index (HSHCI).
  • By Quiddity calculations based on the 21 November close, there is one-way flow across these six indices of HK$26.14bn (approximately), to trade on 5 December at the close.

Weekly Deals Digest (23 Nov) – SBI Shinsei, Toyoda Gosei, Jinke, Digital Hldgs, Webjet, RPM

By Arun George


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Financials: SBI Shinsei Bank, China Merchants Bank H, Wharf Real Estate Investment C and more

By | Daily Briefs, Financials

In today’s briefing:

  • Weekly Deals Digest (23 Nov) – SBI Shinsei, Toyoda Gosei, Jinke, Digital Hldgs, Webjet, RPM
  • A/H Premium Tracker (Week to 21 Nov 2025):  Hs Sharply Underperform As. Year-End Unwinding?
  • Short Wharf REIC: Structural De-Rating and Weakened Luxury Consumption


Weekly Deals Digest (23 Nov) – SBI Shinsei, Toyoda Gosei, Jinke, Digital Hldgs, Webjet, RPM

By Arun George


A/H Premium Tracker (Week to 21 Nov 2025):  Hs Sharply Underperform As. Year-End Unwinding?

By Travis Lundy

  • Hs underperformed As on average by 1.88% within the liquid AH pair universe. Defensive Hs outperform As. Others not.
  • Nine new recos last week. The one labelled saw H underperform A by 2%. Ouch. 15+ new trades this week.
  • The data tables below update on a daily basis in the Tools section of Smartkarma. The Southbound Flow Monitor and AH Pairs Monitor are both there – free – for all SK readers.

Short Wharf REIC: Structural De-Rating and Weakened Luxury Consumption

By Jacob Cheng

  • We think Wharf REIC, which owns luxury malls in Hong Kong, is undergoing a structural de-rating, on the back of macro headwinds, currency impact and company fundamentals
  • Southbound consumption into Hong Kong has weakened deeply, catalyzed by a punitive USD-pegged Hong Kong Dollar (HKD) and a collapsing Japanese Yen (JPY)
  • In latest interim results, Wharf REIC reported HK$5.1 billion revaluation deficit and a HK$2.4 billion net loss, representing negative rental reversions crystallizing into lower asset values.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Yum China Holdings , Tsuruha Holdings, Shanghai Shenzhen CSI 300 Index, Webjet Group, PDD Holdings, Dream International, Lovesac Co and more

By | Consumer, Daily Briefs

In today’s briefing:

  • HSCEI Index Rebalance: 3 Changes; Yum China In; Double Add for Innovent Bio
  • Curator’s Cut: Powering Down CATL, Iron Ore Plays & Japan Consumer Consolidation
  • Asian Stocks Tactical Outlook (Week Nov 24 – Nov 28)
  • Webjet Group (WJL AU): BGH Capital Counters Helloworld with a Competing Proposal
  • Pinduoduo (PDD): 3Q25, Growth Stops Declining, Op Cashflow Rises Again After a Year
  • Shortlist Of High Conviction Ideas: Income, Value, and Margin of Safety – November 2025
  • Primer: Lovesac Co (LOVE US) – Nov 2025


HSCEI Index Rebalance: 3 Changes; Yum China In; Double Add for Innovent Bio

By Brian Freitas


Curator’s Cut: Powering Down CATL, Iron Ore Plays & Japan Consumer Consolidation

By Pranav Rao

  • Welcome to Curator’s Cut — a fortnightly roundup of standout themes from the 1,500+ insights published on Smartkarma.
  • In this cut, we review CATL’s H-share lock-up expiry, iron ore equity opportunities in the face of Simandou’s expected supply, and the accelerating consolidation in Japan’s consumer sector.
  • Want to dig deeper? Comment or message with the themes you’d like to see highlighted next.

Asian Stocks Tactical Outlook (Week Nov 24 – Nov 28)

By Nico Rosti

  • A tactical snapshot of the Asian indices and stocks we cover.
  • Many Asian stocks we track are flashing very oversold signals—creating tactical long setups worth considering.
  • We find no overbought stocks or indices in Asia at present. US equities are aligned with this view, this is a global market pullback, probably about to end.

Webjet Group (WJL AU): BGH Capital Counters Helloworld with a Competing Proposal

By Arun George

  • On 21 November, Webjet Group (WJL AU) disclosed a non-binding takeover offer from BGH Capital at A$0.91 per share, a 1.1% premium to the Helloworld Ltd (HLO AU) offer.
  • BGH’s takeover offer is conditional on a 75% minimum acceptance condition, which is too high a threshold to meet. The acceptance condition is likely to be revised to 50.1%.     
  • Helloworld has justification to engage in a bidding war, particularly due to potential synergies and multiple re-rating. I would expect at least another round of bids. 

Pinduoduo (PDD): 3Q25, Growth Stops Declining, Op Cashflow Rises Again After a Year

By Ming Lu

  • PDD’s total revenue increased by 9% YoY in 3Q25 higher than 7% YoY in 2Q25.
  • In 3Q25, operating cash flows stopped decreasing after a year and grew by 66% YoY.
  • We believe PDD’s stock price can be double for the next twelve month according to other e-commerce companies’ EV/EBITDA.

Shortlist Of High Conviction Ideas: Income, Value, and Margin of Safety – November 2025

By Sameer Taneja


Primer: Lovesac Co (LOVE US) – Nov 2025

By αSK

  • Lovesac is a niche, direct-to-consumer furniture company with a strong brand identity centered on its patented, modular “Sactionals”and premium “Sacs.”
  • The company’s growth is driven by its unique “Designed for Life”philosophy, emphasizing sustainable, adaptable products that foster a loyal, repeat customer base, with approximately 47% of transactions from existing customers.
  • While exhibiting strong long-term revenue growth, the company faces significant near-term headwinds from a challenging macroeconomic environment, increased competition, and margin pressure from promotional activity.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Innovent Biologics Inc, Monash IVF, UltraGreen.ai, 3SBio Inc, Green Thumb Industries and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Hang Seng Index (HSI) Rebalance: Innovent Biologics Turns a Profit, Gets Added
  • Monash IVF (MVF AU): Genesis Capital to Launch a Takeover Proposal?
  • Pre-IPO UltraGreen.ai – Thoughts on the Business, the Concerns and the Valuation
  • 3SBio Inc (1530 HK): Proposed Mandi Spin Off and Listing Sensible; 3SBio Ex Mandi Formidable Enough
  • Primer: Green Thumb Industries (GTII CN) – Nov 2025


Hang Seng Index (HSI) Rebalance: Innovent Biologics Turns a Profit, Gets Added

By Brian Freitas


Monash IVF (MVF AU): Genesis Capital to Launch a Takeover Proposal?

By Arun George

  • The AFR reports that a mystery buyer, believed to be Genesis Capital, will launch a takeover proposal for Monash IVF (MVF AU) at A$0.80, a 31.1% premium to the last close.
  • On Friday, the mystery buyer acquired a pre-bid stake of 6.01% of outstanding shares at A$0.80. The timing is opportunistic as the shares are down 51% YTD.
  • It is unclear whether Genesis is aiming to launch a scheme or an off-market takeover offer. Nevertheless, the rumoured offer is light. 

Pre-IPO UltraGreen.ai – Thoughts on the Business, the Concerns and the Valuation

By Xinyao (Criss) Wang

  • UltraGreen.ai’s IPO valuation of US$1.6 billion is 6x the total 2030 market size for FGS systems. Such valuation is not based on current financial performance but on future growth expectations.
  • For UltraGreen.ai to justify its valuation, it would need to capture a dominant/growing share of this expanding market. This creates a high risk of valuation correction if growth is slower-than-expected.
  • The entire AI sector has been full of bubble.A market-wide correction could impact UltraGreen.ai’s valuation regardless of its individual performance.US$1.3bn is a comfortable valuation for us to invest in UltraGreen.ai.

3SBio Inc (1530 HK): Proposed Mandi Spin Off and Listing Sensible; 3SBio Ex Mandi Formidable Enough

By Tina Banerjee

  • 3SBio Inc (1530 HK) proposed to spin-off and separately list the shares of Mandi, a subsidiary of the company.
  • In 2024 and 1H25, Mandi contributed 16% and 17% of total consolidated sales respectively, while its EBITDA contribution was 14.4% (in 2024) and 11.5% (in 1H25).
  • As far as 3SBio (ex-Mandi) is concerned, marketing approvals for key pipeline product like SSGJ-608, along with indication expansion, geographical expansion of few drugs will be key in near term.

Primer: Green Thumb Industries (GTII CN) – Nov 2025

By αSK

  • Leading U.S. Multi-State Operator with Strong Brand Portfolio: Green Thumb Industries is a vertically integrated cannabis company with a significant presence across 14 U.S. states, operating over 100 retail stores and 20 manufacturing facilities. Its brand portfolio, including Rythm, &Shine, and Dogwalkers, is well-recognized and caters to a wide range of consumers.
  • Path to Profitability and Positive Cash Flow: Unlike many peers in the cannabis industry, Green Thumb has demonstrated a consistent ability to generate positive net income and operating cash flow. This financial discipline allows for strategic expansion and investment in its brands and retail footprint.
  • Positioned for Future Growth from Regulatory Tailwinds: The ongoing trend of cannabis legalization at the state level and the potential for federal rescheduling present significant growth opportunities. Green Thumb’s established presence in key limited-license states positions it to capitalize on these regulatory shifts.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ESG: Financial Institutions Should Accelerate the Reduction of Their Policy Shareholdings and more

By | Daily Briefs, ESG

In today’s briefing:

  • Financial Institutions Should Accelerate the Reduction of Their Policy Shareholdings


Financial Institutions Should Accelerate the Reduction of Their Policy Shareholdings

By Aki Matsumoto

  • During fiscal year 2024, which spans March 2024 to March 2025, the policy-held shares are estimated to have been reduced by approximately 20%.
  • Financial institutions are accelerating their expansion into overseas markets, and as profits from Japanese operations stagnate, the rationale for maintaining cross-shareholdings with Japanese companies is diminishing.
  • Some companies focused on the domestic market wish to continue holding cross-shareholdings due to business relationships. The gap between these companies and those expanding globally is expected to widen further.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): Japan Strategy Weekly | Stimulus Vs. Rising Yields and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Japan Strategy Weekly | Stimulus Vs. Rising Yields
  • APAC Healthcare Weekly (November 23) – 3SBio, Celltrion, Hanmi Pharm, HK Inno.N, Otsuka, CSL
  • Exencial Industry Tidings 21/11/2025


Japan Strategy Weekly | Stimulus Vs. Rising Yields

By Mark Chadwick

  • Japanese equities fell as AI and semiconductor stocks swung sharply, with brief Nvidia-driven optimism fading into week-ending profit-taking that dragged major indices lower.
  • Top performer, Asahi Intecc, jumped about 21% on strong 1Q results, margin gains from productivity efforts, and solid US momentum.
  • Dalton is steadily increasing its Anicom stake amid solid fundamentals, while NAVF builds Eiken holdings and advances governance reforms.

APAC Healthcare Weekly (November 23) – 3SBio, Celltrion, Hanmi Pharm, HK Inno.N, Otsuka, CSL

By Tina Banerjee

  • 3SBio will spin-off and separately list the shares of Mandi, a subsidiary of the company. Celltrion got EC approval for Remsima IV liquid, world’s first liquid formulation of IV infliximab.
  • Hanmi Pharmaceutical is acquiring all of the issued and outstanding common shares of Aptose Biosciences that are not currently owned or controlled by Hanmi.
  • Otsuka got CHMP positive opinion for donidalorsen for the prevention of recurrent attacks of HAE. CSL plans to expand U.S. presence over the next five years, with ~$1.5B U.S. capex.

Exencial Industry Tidings 21/11/2025

By Viral Kishorchandra Shah

  • Vegetable oils & products industry’s sales grow by 22.6% in September 2025 quarter
  • Pesticides industry ‘s sales stagnate in September 20 25 quarter
  • PSU OMCs to source 2.2 mmtpa US LPG priced off Mont Belvieu

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: 3SBio (1530 HK) Plans to Spin-Off and List Mandi in HK – Thoughts on The “Implied” IPO Price and more

By | Daily Briefs, ECM

In today’s briefing:

  • 3SBio (1530 HK) Plans to Spin-Off and List Mandi in HK – Thoughts on The “Implied” IPO Price


3SBio (1530 HK) Plans to Spin-Off and List Mandi in HK – Thoughts on The “Implied” IPO Price

By Xinyao (Criss) Wang

  • 3SBio plans to spin-off and list Mandi on Hong Kong Stock Exchange. The spin-off will allow Mandi to operate independently, with 3SBio ceasing to hold any interest in it post-listing. 
  • Minoxidil is the main performance driver for Mandi. Our forecast is its revenue growth in 2025 would be 15%-20% YoY, with projected revenue range for 2025 of RMB1.538-1.604 billion.
  • Considering Mandi ®’s market leadership position and a growth rate higher than the industry average, we estimate its forward P/S at 20-25x. Then, valuation range for Mandi is RMB31-40 billion.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: SK Square , KT&G Corporation and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Unexpected ETF-Driven Flow Event Lights up the KOSPI 200 IT Sleeve
  • Top 10 Korean Stock Picks and Key Catalysts Bi-Weekly 21 November to 5 December 2025)


Unexpected ETF-Driven Flow Event Lights up the KOSPI 200 IT Sleeve

By Sanghyun Park

  • If the three non-IT names exit IT, passive flows hit hard: SK Square/LG Electronics ~0.4× DTV out, LG Corp ~0.8× DTV out, new IT entrants ~0.2–0.25× DTV in.
  • If KRX surprises next Tuesday, kicking three names from IT, expect immediate tape reaction—market memory exists, but the scenario isn’t priced, unlike 2023 Kakaopay, so instant price impact is likely.
  • If this happens, June 11 turns into a chunky basket-flow day: SK Square (~15% weight) out, next-tier caps see ~0.15–0.2× DTV inflow, except ultra-liquid names like Hanmi Semi.

Top 10 Korean Stock Picks and Key Catalysts Bi-Weekly 21 November to 5 December 2025)

By Douglas Kim

  • In this insight, we provide the top 10 stock picks and key catalysts in the Korean stock market for the next two weeks (21 November to 5 December 2025).
  • Our top 10 picks in the past two weeks (7 to 21 November) were up on average 1.4% this period, outperforming KOSPI which was down 2.5% in the same period.
  • Our top 10 picks in the next two weeks include LG CNS, Hana Financial, Orion Corp, KT&G, Naver, KEPCO E&C, Hanmi Pharm, Amorepacific Corp, LG Chem (Pref), and SK Inc. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: Unexpected ETF-Driven Flow Event Lights up the KOSPI 200 IT Sleeve and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Unexpected ETF-Driven Flow Event Lights up the KOSPI 200 IT Sleeve
  • Asia-Pac M&A Weekly Wrap: RPMGlobal, Insignia, Webjet, Mayne Pharma, Jinke Smart, Digital Holdings
  • Last Week In Event SPACE: 3SBio/Mandi, CATL, Grindr, Mandarin Oriental


Unexpected ETF-Driven Flow Event Lights up the KOSPI 200 IT Sleeve

By Sanghyun Park

  • If the three non-IT names exit IT, passive flows hit hard: SK Square/LG Electronics ~0.4× DTV out, LG Corp ~0.8× DTV out, new IT entrants ~0.2–0.25× DTV in.
  • If KRX surprises next Tuesday, kicking three names from IT, expect immediate tape reaction—market memory exists, but the scenario isn’t priced, unlike 2023 Kakaopay, so instant price impact is likely.
  • If this happens, June 11 turns into a chunky basket-flow day: SK Square (~15% weight) out, next-tier caps see ~0.15–0.2× DTV inflow, except ultra-liquid names like Hanmi Semi.

Asia-Pac M&A Weekly Wrap: RPMGlobal, Insignia, Webjet, Mayne Pharma, Jinke Smart, Digital Holdings

By David Blennerhassett


Last Week In Event SPACE: 3SBio/Mandi, CATL, Grindr, Mandarin Oriental

By David Blennerhassett

  • Given the size of Mandi – relative to 3SBio Inc (1530 HK) – higher market multiples for its in-specie spin-off may have a limited impact on the overall valuation.
  • CATL (3750 HK)  raised around US$5.2bn in its H-share listing in May 2025. The last day for their lockup was the 19th November 2025.
  • While Grindr (GRND US) Special Committee considers the MBO proposal, chairman James Lu has unusually opted to step down. And sell shares below the NBIO price. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars